Cargando…
EZH2 as a Potential Target for NAFLD Therapy
Non-alcoholic fatty liver disease (NAFLD) is a complex disease that is affected by genetic predisposition and epigenetic modification. Deregulation of epigenetic pathways is now recognized as a frequent event in NAFLD, and understanding the mechanistic roles of these epigenetic factors may lead to n...
Autores principales: | Lim, Hyun Jung, Kim, Mirang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697020/ https://www.ncbi.nlm.nih.gov/pubmed/33207561 http://dx.doi.org/10.3390/ijms21228617 |
Ejemplares similares
-
EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
por: Wang, Bohan, et al.
Publicado: (2023) -
Clinical Value of EZH2 in Hepatocellular Carcinoma and Its Potential for Target Therapy
por: Bae, An-Na, et al.
Publicado: (2022) -
The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022) -
EZH2 Down-Regulation Exacerbates Lipid Accumulation and Inflammation in in Vitro and in Vivo NAFLD
por: Vella, Serena, et al.
Publicado: (2013) -
Histone Modifications in NAFLD: Mechanisms and Potential Therapy
por: Shi, Yulei, et al.
Publicado: (2023)